Background-Late vascular responses after implantation of drug-eluting stents may play a key role in steadily increasing occurrence of very late stent thrombosis have not yet been fully investigated in human beings. Methods and Results-Serial optical coherence tomography observations at 2 and 4 years were collected for 17 patients treated with 21 sirolimus-eluting stents. Corresponding 376 cross sections within single-stent segments at intervals of 1 mm were selected for analyses, and neointimal thickness on each strut was measured. Extrastent lumen (ESL) was defined as an external lumen of the stent. Area and angle of ESL were measured. A total of 3369 and 3221 struts were identified at 2 and 4 years, respectively. From 2 to 4 years, mean neointimal thickness increased (76.8Ϯ75.6 m versus 123.0Ϯ102.5 m; PϽ0.0001), whereas frequency of patients with uncovered struts decreased (88% versus 29%; Pϭ0.002). Although prevalence of patients that had ESL was similar (59% of 2 years versus 65% of 4 years; Pϭ1.0), the cross sections with ESL increased (9.6% versus 15.2%; Pϭ0.02). Moreover, area and angle of ESL increased from 2 to 4 years (0.28Ϯ0.27 mm 2 versus 0.62Ϯ0.68 mm 2 and 16.6Ϯ5.4°versus 65.1Ϯ38.4°; PϽ0.01, respectively). The incidence of subclinical thrombus did not decrease (24% at 2 years versus 29% at 4 years; Pϭ1.0). All thrombi were identified in patients who had cross sections with ESL. Conclusions-The current serial optical coherence tomography study showed an augmentation of neointimal growth at the late phase of sirolimus-eluting stent implantation. ESL may contribute to thrombus formation and ESL of sirolimuseluting stents expanded from 2 to 4 years. (Circ Cardiovasc Interv. 2010;3:476-483.)
I n recent years, occurrence of very late stent thrombosis (VLST; Ն12 months) after drug-eluting stent (DES) implantation has become a major clinical issue because VLST is an infrequent complication, but it can lead to serious events such as acute myocardial infarction and sudden cardiac death. [1] [2] [3] [4] VLST, a specific phenomenon to coronary intervention using DES, occurs steadily at an annual rate of 0.4% to 0.6% for up to 4 years without reaching a plateau. 5, 6 Previous pathological investigations reveal that incomplete arterial healing, characterized by an delayed endothelial coverage and the persistence of fibrin deposition around stent struts, plays a key role in the VLST of DES. 7, 8 Moreover, the most powerful morphometric predictor of VLST is the ratio of uncovered struts lacking of endothelialization to total struts per section of Ͼ0. 3. 8 
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Optical coherence tomography (OCT) is a new intracoronary imaging modality with a high axial resolution of approximately 10 to 20 m, which is 10-fold higher than that of intravascular ultrasound (IVUS). 9, 10 Although discrimination between thin neointimal tissue from fibrin deposition on the struts is complicated, this imaging tool can identify uncovered struts. 10 -14 In addition, length (or thickness), area, and angle are quantitatively evaluated by OCT measurements. We previously reported that incomplete neointimal stent coverage and the existence of uncovered struts persist for up to 2 years after deployment of sirolimus-eluting stents (SES), one of the representatives of first-generation DES. 14, 15 However, late vascular responses to SES over 2 years have not been fully examined in living patients. Therefore, the current OCT examination focusing on uncovered struts and lumen changes within SES segments was serially performed from 2 to 4 years after stenting.
Methods

Patient Population
Intracoronary OCT and angiographic follow-up examinations were performed 2 years after SES implantation for 21 patients, as we had reported previously. 14 The exclusion criteria of this study were (1) lesions in unprotected left main coronary artery and ostial lesions, (2) restenotic lesions receiving target lesion revascularization before the 4-year follow-up, (3) patients with chronic renal failure (serum creatinine Ն2.5 mg/dL) without regular hemodialysis, and (4) patients with a severely reduced left ventricle systolic function (ejection fraction Ͻ30%), and (5) patients who did not give their consent to undergo follow-up examinations. With the final inclusion of 21 patients, follow-up examinations given at 4 years after the initial SES placement were prospectively attempted between December 2009 and February 2010, regardless of the absence of their chest symptoms. The Medical Ethics Committee at our institution approved this study protocol, and written informed consent was obtained from all patients before participation. Patient demographics were obtained on the basis of a hospital chart review.
Angiographic Analysis
Coronary angiography was performed after administration of heparin (2000 IU). Angiograms were analyzed with a computer-assisted, automated edge detection algorithm (CMS, MEDIS, Nuenen, The Netherlands) by an investigator blinded to the patient information using standard quantitative coronary angiography measurements. Restenosis was defined as Ն50% diameter stenosis in the stent segment and the adjacent proximal and distal 5 mm peristent regions at the follow-up examination. Abnormalities on fluoroscopy and angiography, such as stent fracture, haziness, filling defects, aneurismal formation (Ն1.5 times of reference vessel diameter), 16 or peristent contrast stains, were qualitatively assessed.
OCT Procedures
Patients were intravenously given additional heparin (2000 IU) before the OCT procedure. A 6F guiding catheter was engaged into the coronary artery by a transradial approach, and nitroglycerin (200 g) was administered through the guiding catheter. OCT imaging system (Model M2 Cardiology Imaging System, LightLab Imaging, Inc, Westford, Mass), an occlusion balloon catheter (Helios, Goodman Corp, Nagoya, Japan), and a 0.016-inch wire-type image catheter (ImageWire, LightLab Imaging, Inc) were used for image acquisition. 11, 12 The image catheter was pulled back from distal to proximal with a motorized system at 1.0 mm/s, and continuous images through the whole stent segments were digitally stored for the subsequent analyses.
OCT Image Analysis
OCT images were analyzed at intervals of 1 mm after calibration adjustment, and the locations of cross sections between the 2-year and 4-year examinations were completely fitted to each other. For the image matching, distance from the stent edge and landmarks such as side branches, distribution of the stent struts, and calcified plaques were used. Inadequate images, including noncircumferential cross sections caused by imaging wire bias and cross sections with bifurcations of major side branches (Ͼ 2 mm of the diameter), were excluded from the analyses. Stent-overlapping segments were also excluded because of incorrect traces of the outer stent due to limited penetration depth of OCT images and backscattering by the inner stent struts. Neointimal thickness (NIT) on each stent strut was measured. Uncovered strut was defined as a strut of measured NIT equal to 0 m, and malapposed strut was a strut of distance between its surface and the adjacent vessel surface Ͼ160 m (the thickness of strut and polymer layers) according to the previous reports. 11, 12 Uncovered strut ratio (UCSR) in each cross section was calculated as follows: 8, 14 UCSRϭnumber of uncovered struts/number of total struts
The outlines of stent and lumen were traced for area measurements. In a cross section that had an external lumen of the stent, the lumen was defined as extrastent lumen (ESL). Both lumen of incomplete stent apposition (ISA) with malapposed struts and excavated lumen without malapposed struts were included in ESL. Area, angle (summation per cross section), and depth (maximum distance from adjacent vessel surface to the outline of stent) of ESL were analyzed for each cross section with ESL ( Figure 1 ). Neointimal area and percent neointimal area were calculated as follows:
Neointimal areaϭstent area (ϩESL)Ϫlumen area (mm 2 ) Percent neointimal areaϭneointimal area/stent areaϫ100 (%)
In volumetric analysis, volumes of the stent, lumen, neointima, and ESL were counted by integral calculus. An in-stent thrombus was defined as an irregular mass protruding into the lumen and was classified into red thrombus with marked backscattering or white thrombus without that. 17 Interobserver and intraobserver variability was assessed by the evaluation of 50 random cross-sectional images by 2 independent readers blinded to patient information and by the same reader at 2 separate time points, respectively. Intraobserver agreement for ESL and thrombus was 98% and 93%, respectively. Interobserver agreement for them was 93% and 90%, respectively. If no consensus was obtained, then a third reader judged the images. Intraobserver variability for the measurements of ESL (area, angle, and depth) was 0.3Ϯ0.5 mm 2 , 2.4Ϯ1.6°, and 7Ϯ8 m, respectively. Interobserver variability was 0.3Ϯ0.4 mm 2 , 2.6Ϯ1.9°, and 9Ϯ8 m, respectively.
Statistical Analysis
Categorical variables are presented as frequencies, and they were analyzed by either 2 test or Fisher exact test. Continuous quantitative data are presented as meanϮSD. In analysis for corresponding data between 2 years and 4 years, quantitative data were compared by paired Student t test and categorical outcomes were tested by the McNemar test. A value of PϽ0.05 was considered to be statistically significant. 
Results
Clinical Characteristics
Among the 21 patients at the 2-year examination point, 1 patient died of renal cell carcinoma and 2 patients did not agree to undergo a reexamination at 4-year follow-up. Another patient underwent target lesion revascularization for restenosis at the 2-year time point. Finally, 17 patients were enrolled and their 17 stent segments (21 SES) were examined. All results are presented for 17 segments in 17 patients. The time from SES implantation to the current examination was 55.3Ϯ6.2 months, and all patients were asymptomatic. The patient characteristics at 4 years are presented in Table 1 . Dual antiplatelet therapy was maintained in 15 patients at 2 years and in 12 patients at 4 years. Diameter of the SES (nϭ21) was 2.9Ϯ0.3 mm, and there were 4 stent-overlapping segments in 3 patients.
Angiographic Findings
Angiographic findings are shown in Table 2 . Average decrease in minimum lumen diameter between 2 to 4 years was 0.11Ϯ0.13 mm. Changes in quantitative coronary angiography parameter between 2 and 4 years were significant except for reference vessel diameter. In 2 patients, peristent contrast stains were recognized as qualitative abnormal findings at 4 years. In-stent restenosis did not appear during this period. Moreover, there were no major adverse cardiac events derived from the SES segments or other coronary segments.
OCT Findings
Total stent length was 428 mm (ϭ428 cross sections). The cross sections in stent-overlapping segments (nϭ19), in bifurcations (nϭ5), and those of inadequate images (nϭ15 at 2 years and nϭ13 at 4 years) were excluded, and 376 cross sections corresponding with the 2 follow-ups were selected for the image analyses.
The results of OCT analysis are summarized in Table 3 . In the objective cross sections, 3369 and 3221 stent struts were identified at 2 years and 4 years, respectively. From 2 to 4 years, NIT increased, whereas uncovered struts decreased. Distributions of NIT at intervals of 50 m are shown in Figure 2 . The peak of NIT shifted from 2 to 4 years (10 to 50 m and 60 to 100 m, respectively). Although stent area did not change significantly, both neointimal area and ESL area increased. As volumetric analysis showed, increase in neointimal volume was greater than that in ESL volume. Consequently, lumen area and volume decreased during the follow-up. Ratio of cross sections with ESL to total number of cross sections increased. At 4 years, the cross sections with ESL were located at the proximal segment in 35%, at the stent body in 51%, and at the distal segment in 14%. Frequency of malapposed struts and area and angle of ESL increased (Figure 3 and 4 ). Prevalence of patients with uncovered struts decreased, and those with cross sections of UCSR Ͼ0.3 tended to decrease (88% versus 29% and 35% versus 6%, respectively). Although a new appearance of ESL was found in 1 patient, the frequency of patients with ESL did not differ (59% of 2 years versus 65% of 4 years Pϭ0.59). The incidence of in-stent thrombus did not decrease during the study period (24% at 2 years versus 29% at 4 years) ( Figure 5 ). All thrombi were identified in the patients who had cross sections with ESL, despite the fact that patients with ESL and/or thrombus at 2 years had received dual antiplatelet therapy. Red thrombus was observed in 2 patients of 2 years and in 1 patient of 4 years, and 2 patients at 2 years and 4 patients at 4 years had white thrombus. In the cross sections with ESL, 2 thrombi at 2 years and 3 thrombi at 4 years arose. The other 4 thrombi were located adjacent to the cross sections with ESL (distance from thrombus to cross section with ESL, 1.8Ϯ1.0 mm).
Discussion
The present study demonstrated that uncovered stent struts decreased and NIT increased without inducing angiographic restenosis "catch-up" from 2 to 4 years after SES implantation. Furthermore, malapposed struts and size of ESL increased during the follow-up period. Serial OCT measurements certified a significant increase in NIT and neointimal area of the SES segments despite a minimum advance in stenosis on quantitative coronary angiography. The peak of distributions of measured NIT shifted from 10 to 50 m at 2 years to 60 to 100 m at 4 years. These OCT findings suggested that neointimal growth is a vascular healing response to SES that progresses at the late phase of their implantation. Previous serial or fractional OCT investigations into SES confirmed imperceptible increase in NIT for up to 2 years. 14, 18 Together with these facts, the neointima of SES thickened gradually up to 4 years. Although more than half of the struts (54.4% of 4-year) had an NIT Յ100 m, these are still beyond the image resolution of IVUS. The difference of an identifiable NIT between IVUS and OCT probably affect the measurements for neointimal area and volume by the 2 imaging devices. The proportion of neointima to stent lumen (percent intimal hyperplasia volume) on IVUS data were only 5.7% to 9.1% at 4 years. 19 However, similar index as percent neointimal area of this study was 24.9%. High-resolution OCT images may therefore have an advantage in accurately estimating thin neointimal growth over IVUS.
Patients with any uncovered strut decreased and those with cross section of UCSR Ͼ0.3 tended to decrease from 2 to 4 years. To date, persistence of the cross section insufficiently covered with neointima is the most reliable marker for VLST according to histopathologic validation. 8 Together, these changes are considered to be favorable phenomena for reducing a risk of thrombus formation or closing VLST. In our series, OCT accounted for uncovered struts of 3.2% at 2 years and 0.9% at 4 years. Conversely, the majority of stent struts were regarded as struts with an achievement of neointimal coverage. Nevertheless, it has been reported that fibrin accumulation persists around the struts lacking endothelium and mean percent endothelialization of DES is no more than 60%, regardless of implant duration. 7, 8 In morphometric analysis, 49.3% of the DES struts (implant duration, 223Ϯ253 days) certainly have fibrin deposition. 7 The peristrut fibrin layer is partially regarded as proliferation of neointimal tissue on OCT findings, and OCT overestimates the neointimal stent coverage. This major problem may significantly affect the results and may lead to interpretation opposite to the current findings of progress in neointimal stent coverage as a beneficial vascular response.
The results of the current study emphasized that ESL area and frequency of the cross section with ESL increased between 2 and 4 years after SES implantation. Although ESL expanded during this period, vessel lumen containing ESL decreased. As the volumetric data showed, the augmented neointimal growth is superior to the expansion of ESL in the to 400, 410 to 450, 460 to 500, and Ն510 m are 3.2%, 47.8%, 24.6%, 13.2%, 5.4%, 2.7%, 1.3%, 0.5%, 0.4%, 0.2%, 0.3%, and 0.3%, respectively. Those of 4 years are 0.9%, 24.7%, 28.8%, 20.7%, 9.7%, 5.9%, 3.7%, 1.8%, 1.1%, 0.7%, 0.7%, and 1.1%, respectively. The peak of NIT differs between 2 years and 4 years (10 to 50 m and 60 to 100 m, respectively).
limited cross sections of 15.2%. An increase in malapposed struts was another remarkable finding of a late morphological variation after SES deployment. We have no marker for complete endothelialization in the surrounding tissue of malapposed struts. As in Figures 3 and 4 , the new appearance of ESL contributed to the occurrence of malapposed struts. This phenomenon may be equivalent to late-acquired ISA on IVUS findings. 16,20 -23 Although area, angle, and depth of OCT-derived ESL were not drastic, prevalence of ESL in event-free patients of this study (65% at 4 years) was more frequent in comparison to the IVUS data on ISA. 20, 23 By contrast, ESL showed a location similar to ISA in patients with VLST. 20, 23 The principal mechanism of late-acquired ISA is considered dilatation of external elastic membrane area in a time course, so-called positive arterial remodeling caused by localized inflammation including hypersensitivity to SES polymer. 20 -22 In addition, a novel OCT finding of a peristrut ulcer-like appearance, characterized by a wavy contour of the lumen without malapposed struts, was also related to ESL. It was uncertain whether positive vessel remodeling causes the manifestation and enlargement of ESL, because scanning area of OCT is relatively narrow to that of IVUS. Considering the drug-release kinetics of SES, it is reasonable that sustained vascular response to mature SES, for instance, chronic inflammation or hypersensitive reaction to the residual stent polymer, participates in the expansion of ESL at late phase. Roughly 150 struts of 2-year follow-up were lost at 4 years, despite the analysis of fitted cross sections. The main reason was thought to be that high-signal regions underneath the lumen interrupt visualization of the struts. As several reports implied, 24, 25 an increased signal intensity of neointima may be provoked by inflammatory or atherosclerotic changes.
With regard to in-stent thrombus, the number of thrombi increased between 2 and 4 years despite statistically no significance. Persistence of incomplete endothelialization and presence of ISA possibly bring thrombus formation. 7,8,16,20 -22 Therefore, prolonged exposure of the uncovered struts identified by OCT to the lumen was considered potentiality for persistent thrombogenicity of SES. Angioscopic studies at late follow-up also suggest fresh thrombus formation associating with incomplete neointimal stent coverage. 15, 26 Moreover, an expanding ESL and increasing malapposed struts from 2 to 4 years may serve as a local nidus for the thrombus formation by allowing for platelet adhesion and fibrin deposition as well as ISA. 27 ESL, interspace between excavated vessel wall and malapposed struts, may reduce coronary blood flow and help to create sufficient conditions for the initiation and promotion of thrombotic cascade. Actually, every patient with thrombus had cross sections with ESL, and these facts may support the notion of thrombogenicity connecting to ESL. Although OCT identified several silent thrombi within SES segments, all patients of the current study were free from major adverse cardiac events, including VLST. It is likely that a huge ISA on IVUS findings often have direct linkage with the occurrence of VLST. 20, 22 The amplitude of OCT-derived ESL in this study may be powerless to inflame VLST in the clinical settings.
Continuous but not drastic alterations of the lumen features were recognized as late vascular responses to SES. Although long-term follow-up examination by OCT was carried out, we failed to confirm the static environment within the SES segment. Furthermore, in-stent thrombus relevant to the expanding ESL did not decrease from 2 to 4 years. The cumulative incidence of VLST is still increasing, 5, 6 and therefore careful and further extended follow-up studies will be required for the patients treated with SES.
Limitations
First, our findings were based on observations in a relatively small number of patients and selected cross sections. Second, our information on stent-overlapping segments and vessel remodeling was absent because of a limited penetration depth and scanning area of OCT. Alternatively, serial investigation for corresponding cross sections in single stent segments provides detailed changes. Third, it was unclear when preexisting ESL of 2 years is built up. In other words, we cannot exactly determine whether that was procedure-related or acquired ESL. Fourth, there are no long-term OCT data concerning the other DES because SES is the initial DES for human use. Recent in vivo or ex vivo research by angioscopy, OCT, and microscopy showed differential healing responses in first-generation DES. 13, 22, 28, 29 Nevertheless, it was questionable that the disclosed changes are unique to SES. Finally, genuine endothelialization could not be verified, even though we used micron-scale OCT. Technological development will guarantee for discrimination between fibrin layer and neointimal tissue in the future.
Conclusion
The current serial OCT study showed a significant decrease in uncovered struts accompanied by continuous neointimal growth of SES between 2 and 4 years. On the other hand, ESL correlated with thrombus formation continually expanded for up to 4 years after SES implantation. Figure 2 . Appearance of malapposed struts (blue arrowheads) and ESL (red arrowheads) is newly found. There is some tissue around the malapposed struts. It is unclear whether the tissue is endothelialized neointima or fibrin deposition. Moreover, the preexisting ESL expand from 2 to 4 years (white arrowhead), and pronounced peristent ulcer-like regions are recognized (white arrows). A small thrombus (red arrow) also appears in the cross section with ESL.
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Serial OCT Observations for SES 481 Figure 5 . Prevalence of patients with uncovered strut, cross section of uncovered strut ratio Ͼ0.3, cross section with extrastent lumen, and thrombus. Patients with any uncovered strut decreased and those with cross section of uncovered strut ratio (UCSR) Ͼ0.3 tended to decrease from 2 to 4 years. On the other hand, patients had any cross section with ESL and incidence of in-stent thrombus did not decrease during this period.
